AU Patent

AU2007325628A1 — Nanoparticulate formulations and methods for the making and use thereof

Assigned to Immedica Pharma US Inc · Expires 2008-06-05 · 18y expired

What this patent protects

Patent listed against sotalol-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
AU2007325628A1
Jurisdiction
AU
Classification
Expires
2008-06-05
Drug substance claim
No
Drug product claim
No
Assignee
Immedica Pharma US Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.